EVERSANA and MyHealthTeam launch groundbreaking direct-to-patient solution to accelerate time to diagnosis and treatment
The new offering will help life science and pharmaceutical brands create better and more personalized experiences for both diagnosed and undiagnosed patient populations, accelerating paths to diagnosis and treatment, and creating unmatched educational opportunities. Brand teams will gain unmatched insights into what patient communities are saying and looking for, and then serve up customized content to help them at any stage of the patient journey.